Harmony Biosciences HRMY Stock
28.75 USD
{{ price }}
-2.641384%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
1.65B USD
LOW - HIGH [24H]
27.72
-
29.58 USD
VOLUME [24H]
878.83K USD
{{ volume }}
P/E Ratio
11.45
Earnings per share
2.51 USD
Harmony Biosciences Price Chart
Harmony Biosciences HRMY Financial and Trading Overview
| Harmony Biosciences stock price | 28.75 USD |
| Previous Close | 35.76 USD |
| Open | 35.74 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1200 |
| Day's Range | 35.73 - 36.28 USD |
| 52 Week Range | 29.81 - 62.09 USD |
| Volume | 265.93K USD |
| Avg. Volume | 876.19K USD |
| Market Cap | 2.17B USD |
| Beta (5Y Monthly) | 0.446334 |
| PE Ratio (TTM) | 11.550955 |
| EPS (TTM) | 2.51 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60.11 USD |
HRMY Valuation Measures
| Enterprise Value | 1.99B USD |
| Trailing P/E | 11.550955 |
| Forward P/E | 10.699115 |
| PEG Ratio (5 yr expected) | 0.49 |
| Price/Sales (ttm) | 4.6103473 |
| Price/Book (mrq) | 4.907984 |
| Enterprise Value/Revenue | 4.228 |
| Enterprise Value/EBITDA | 12.678 |
Trading Information
Harmony Biosciences Stock Price History
| Beta (5Y Monthly) | 0.446334 |
| 52-Week Change | -17.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 62.09 USD |
| 52 Week Low | 29.81 USD |
| 50-Day Moving Average | 34.34 USD |
| 200-Day Moving Average | 45.45 USD |
HRMY Share Statistics
| Avg. Volume (3 month) | 876.19K USD |
| Avg. Daily Volume (10-Days) | 430.19K USD |
| Shares Outstanding | 59.94M |
| Float | 38.07M |
| Short Ratio | 14.47 |
| % Held by Insiders | 18.87% |
| % Held by Institutions | 90.10% |
| Shares Short | 8.02M |
| Short % of Float | 36.27% |
| Short % of Shares Outstanding | 13.38% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 40.17% |
| Operating Margin (ttm) | 28.20% |
| Gross Margin | 81.01% |
| EBITDA Margin | 33.35% |
Management Effectiveness
| Return on Assets (ttm) | 14.10% |
| Return on Equity (ttm) | 57.62% |
Income Statement
| Revenue (ttm) | 471.67M USD |
| Revenue Per Share (ttm) | 7.94 USD |
| Quarterly Revenue Growth (yoy) | 39.60% |
| Gross Profit (ttm) | 354.37M USD |
| EBITDA | 157.3M USD |
| Net Income Avi to Common (ttm) | 189.47M USD |
| Diluted EPS (ttm) | 3.14 |
| Quarterly Earnings Growth (yoy) | 37.20% |
Balance Sheet
| Total Cash (mrq) | 343.88M USD |
| Total Cash Per Share (mrq) | 5.74 USD |
| Total Debt (mrq) | 194.18M USD |
| Total Debt/Equity (mrq) | 43.83 USD |
| Current Ratio (mrq) | 4.898 |
| Book Value Per Share (mrq) | 7.39 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 158.17M USD |
| Levered Free Cash Flow (ttm) | 134.22M USD |
Profile of Harmony Biosciences
| Country | United States |
| State | PA |
| City | Plymouth Meeting |
| Address | 630 West Germantown Pike |
| ZIP | 19462 |
| Phone | 484 539 9800 |
| Website | https://www.harmonybiosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 200 |
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Q&A For Harmony Biosciences Stock
What is a current HRMY stock price?
Harmony Biosciences HRMY stock price today per share is 28.75 USD.
How to purchase Harmony Biosciences stock?
You can buy HRMY shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Harmony Biosciences?
The stock symbol or ticker of Harmony Biosciences is HRMY.
Which industry does the Harmony Biosciences company belong to?
The Harmony Biosciences industry is Biotechnology.
How many shares does Harmony Biosciences have in circulation?
The max supply of Harmony Biosciences shares is 57.39M.
What is Harmony Biosciences Price to Earnings Ratio (PE Ratio)?
Harmony Biosciences PE Ratio is 11.45418400 now.
What was Harmony Biosciences earnings per share over the trailing 12 months (TTM)?
Harmony Biosciences EPS is 2.51 USD over the trailing 12 months.
Which sector does the Harmony Biosciences company belong to?
The Harmony Biosciences sector is Healthcare.
Harmony Biosciences HRMY included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16823.17 USD — |
-0.05
|
6.87B USD — | 16753.22 USD — | 16979.96 USD — | — - | 6.87B USD — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1295.06 USD — |
-0.48
|
— — | 1287.93 USD — | 1308.77 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2668.51 USD — |
+0.5
|
— — | 2660.45 USD — | 2688.91 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4010.46 USD — |
-0.39
|
— — | 3978.56 USD — | 4047.74 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 898.33 USD — |
-0.3
|
— — | 891.62 USD — | 905.39 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1984.88 USD — |
-0.07
|
— — | 1976.77 USD — | 2006.81 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1758.63 USD — |
+0.01
|
— — | 1740.1 USD — | 1772.91 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}